Synairgen (SNG)

 

Latest News

Posting of Annual Report and Notice of AGM

RNS Number: 3419O Synairgen plc 17 May 2018 Press release Synairgen plc ('Synairgen' or the 'Company') Posting of Annual Report and Notice of AGM Southampton, UK - 17 May 2018: Synairgen (LSE: SNG), the respiratory drug discovery and development company, announces that on 17 May 2018 it posted its full Audited Report and Accounts for the twelve months...

Holding(s) in Company

RNS Number: 0805L Synairgen plc 16 April 2018 Synairgen plc ('Synairgen' or the 'Company') Holding in Company Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was today informed that Leonard Licht, a private investor, now holds 6,650,000 ordinary shares of 1 pence each in the capital of t...

Grant of Options

RNS Number: 1396K Synairgen plc 06 April 2018 Press Release Synairgen plc ('Synairgen' or the 'Company') Grant of options Southampton, UK - 6 April 2018: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that o n 5 April 2018 the Board of Synairgen granted options ('Options') over 2,822,316 ordinary shares of one penc...

Holding(s) in Company

RNS Number: 7053J Synairgen plc 03 April 2018 Synairgen plc ('Synairgen' or the 'Company') Holding in Company Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was today informed that Leonard Licht, a private investor, now holds 6,000,000 ordinary shares of 1 pence each in the capital of t...

All News

DateHeadlineSource
17-05-18Posting of Annual Report and Notice of AGMRNS
16-04-18Holding(s) in CompanyRNS
06-04-18Grant of OptionsRNS
03-04-18Holding(s) in CompanyRNS
15-03-18Issue of EquityRNS
15-03-18Holding(s) in CompanyRNS
15-03-18Synairgen swings to profitStockMarketWire
15-03-18Preliminary results for year ended 31 Dec 2017RNS
07-02-18Synairgen commences trail of obstructive pulmonary disease treatmentStockMarketWire
07-02-18Broker Forecast - finnCap issues a broker note on Synairgen PLCStockMarketWire
07-02-18Synairgen starts dosing in Phase II COPD studyRNS
14-12-17Synairgen revises collaboration with PharmaxisStockMarketWire
14-12-17Update on LOXL2 Programme&Pharmaxis CollaborationRNS
08-11-17Holding(s) in CompanyRNS
27-09-17Interim results for six months ended 30 June 2017RNS
27-09-17Data update and clinical plan for COPDRNS
13-09-17Holding(s) in CompanyRNS
06-09-17Synairgen's PXS-5382A to be prepared for Phase I clinical developmentStockMarketWire
06-09-17LOXL2 Inhibitor Update.RNS
28-06-17Synairgen shareholders pass all resolutions at AGMStockMarketWire
28-06-17Result of AGMRNS
05-06-17Posting of Annual Report and Notice of AGMRNS
17-05-17Preliminary ResultsRNS
27-04-17US tax reform plans and ex-dividends push FTSE lower StockMarketWire
27-04-17Synairgen updates on AZD9412StockMarketWire
27-04-17AZD9412 UpdateRNS
27-03-17Holding(s) in CompanyRNS
13-03-17Holding(s) in CompanyRNS
10-03-17Additional Positive Data in Lung FibrosisRNS
17-01-17Holding(s) in CompanyRNS
13-10-16Holding(s) in CompanyRNS
12-10-16Synairgen updates on AZD9412StockMarketWire
12-10-16FTSE up on airlines, house builders after sluggish startStockMarketWire
12-10-16AZD9412 Clinical Trial UpdateRNS
22-09-16Broker Forecast - N+1 Singer issues a broker note on Synairgen PLCStockMarketWire
22-09-16Synairgen widens H1 pretax lossStockMarketWire
22-09-16Interim results for six months ended 30 June 2016RNS
08-09-16Notice of Interim ResultsRNS
14-06-16Result of AGMRNS
07-06-16Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?Motley Fool

RSS feeds

  • Editorial news feed for LSE:SNG Editorial
  • Regulatory news feed for LSE:SNG Regulatory